Method and composition to increase radiation-induced tumor therapeutic effects

Details for Australian Patent Application No. 2010328335 (hide)

Owner Memorial Sloan-Kettering Cancer Center

Inventors Kolesnick, Richard N.; Stancevic, Branka; Sadelain, Michel; Fuks, Zvi; Varda-Bloom, Nira

Agent Pizzeys

Pub. Number AU-A-2010328335

PCT Pub. Number WO2011/071859

Priority 61/283,696 08.12.09 US

Filing date 7 December 2010

Wipo publication date 16 June 2011

International Classifications

C12N 9/16 Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

A61K 38/00 Medicinal preparations containing peptides

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/861 Mutation or genetic engineering - Adenoviral vectors

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/071859 Priority application(s): WO2011/071859

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010328336-Compositions for nucleic acid delivery

2010328325-Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications